Affinity Asset Advisors, LLC Axsome Therapeutics, Inc. Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 80,000 shares of AXSM stock, worth $6.96 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
80,000
Previous 80,000
-0.0%
Holding current value
$6.96 Million
Previous $6.44 Million
11.61%
% of portfolio
1.24%
Previous 0.88%
Shares
7 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$364 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$287 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$205 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$90.9 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.73B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...